We are pleased to present our latest Corporate film.

A few minutes that embody the passion for our professions, our expertise and the values ​​that guide us on a daily basis.
At Provepharm, we have been valuing the full potential of each molecule for 25 years now, in order to provide innovative treatments. And tomorrow, we will continue to fulfill our mission to act to improve the lives of patients, our employees and our ecosystem.

Find the testimonials of employees who contribute to the success of the company. 

07/19/2023

On Tuesday July 18, 2023, the 140 Provepharm employees, some of whom came from the USA and the UK, celebrated the quarter century of the pharmaceutical laboratory in an emblematic place in Marseille, Casa Delauze.

The opportunity for Michel Feraud, Founder and CEO of Provepharm to recall the path traveled in 25 years to become the pioneer of the 3rd way. Today, Provepharm is:
- Innovative reference products distributed in more than 30 countries,
- Obtaining patents & MAs*: in Europe, the United States, worldwide,
- The opening of subsidiaries in Europe, the United States, England,
- Daily innovation in its own production unit in Marseille at the Technopôle de Château-Gombert,
- Offices: in Marseille, Philadelphia, New York and more recently in London

It is an entrepreneurial adventure that is evolving into a group with an international dimension, while retaining its DNA and its values ​​of audacity, commitment and integrity.
For 25 years, our mission has never changed explains Michel Feraud "To improve the lives of patients, our employees and our ecosystem". It is moreover the whole ecosystem of the group which met on the occasion of this anniversary to exchange and share a convivial moment.
 

* Marketing Authorization

06/14/2023

The 18th annual event of ETPN & the 5th ENM conference merged into a unique event: #NME23 

The largest conference dedicated to #Nanomedicine in #Europe, organized by the European Technology Platform for Nanomedicine (ETPN Association) in collaboration with the British Society for Nanomedicine and the University of Liverpool. 

NME23 brings together scientists, technology providers, entrepreneurs, industry and clinicians, all developing major medical applications of nanotechnologies and emerging MedTech. 

Come and meet us !  

03/30/2023

At Provepharm Life Solutions, we innovate to realize each molecule's full potential, to provide treatments that help improve patients' lives.

Provepharm - 2022 At a glance

12/19/2022

All Provepharm Life Solutions employees wish you happy holidays and All the Best for 2023.

Discover our wishes in video!

10/26/2022

10/13/2022

The green index is a reference tool created in 2012 by the CAHPP which measures the sustainable commitment of suppliers to healthcare establishments. The Provepharm teams are happy to have obtained the label's A mention for the first time this year. This rewards everyone's CSR commitment and our desire to develop Responsible purchases in Healthcare.

09/26/2022

Provepharm will participate for the first time in the National Training Days on medical devices organized by Euro-pharmat, which will be held in La Rochelle from October 4 to 6, 2022.

Our sales team will welcome delegates to the Provepharm stand to introduce them to our range of endoscopic and surgical dyes, and discuss good practices and recommendations for good use. Let’s contribute together to improving patient care! You will find the program of this congress HERE (in French only).

Looking forward to meeting you on this occasion.

09/05/2022

For the third consecutive year, Provepharm will participate in the "Convergences Santé Hôpital" Meetings, which will take place from September 13 to 16, 2022 at the Neptune Convention Center in Toulon.

This congress, organized by the SNPHPU*, is one of the main crossroads of exchanges between Hospital Pharmacists and French health actors, and promotes research on new perspectives such as the latest therapeutic innovations or the optimization of the functions devolved to the professionals at the service of the patient. In September, Toulon will bring together all the health practitioners and players who make up today's public and private hospitals. The sales, medical and marketing teams will welcome all the delegates to our PROVEPHARM stand near the auditorium, to discuss current topics, present our entire range of hospital products and our activities for hospital pharmacists. More information here (in French only).

*National Union of Hospital Pharmacists

07/19/2022

Our CSR report, published for seven years on the Global Compact website, has become an essential medium for promoting our voluntary and ambitious approach to all of our stakeholders. Internally, it allows us to take stock of our actions, but also contributes to making our CSR approach an essential element of Provepharm's culture.

With the annual publication of our CSR Report, we renew our desire to include and promote the 10 principles of the United Nations Global Compact relating to human rights, working conditions, environmental protection and the fight against corruption, as part of our progress approach.

In summary :

1. Our CSR commitments and objectives for 2025
2. Responsibility at the heart of our production
3. A requirement: operational excellence
4. All mobilized to act in favor of our planet
5. Putting customers and patients at the heart of our business
6. An ecosystem in line with our vision
7. A positive impact on the territory

Rapport RSE 2022